Cargando…
Prioritization of Vaccines for Inclusion into China’s Expanded Program on Immunization: Evidence from Experts’ Knowledge and Opinions
Background: Vaccine developers in China have made an increasing number of infectious diseases preventable through vaccination. An appropriate decision-making procedure is necessary for making wise decisions on whether to introduce new vaccines into the Expanded Program on Immunization (EPI). When th...
Autores principales: | Ma, Chao, Li, Junhong, Wang, Nan, Wang, Yamin, Song, Yudan, Zeng, Xiang, Zheng, Canjun, An, Zhijie, Rodewald, Lance, Yin, Zundong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318118/ https://www.ncbi.nlm.nih.gov/pubmed/35891174 http://dx.doi.org/10.3390/vaccines10071010 |
Ejemplares similares
-
The National Immunization Advisory Committee in China: Roles of National Experts in Making Evidence-Based Recommendations for Immunization
por: Ma, Chao, et al.
Publicado: (2019) -
Senior Research Scholars in China CDC’s National Immunization Program
por: Wang, Miao, et al.
Publicado: (2021) -
Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China
por: An, Zhijie, et al.
Publicado: (2021) -
Survey on Immunization Services for Children with Medical Conditions — China, 2022
por: Huang, Yong, et al.
Publicado: (2023) -
Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021
por: Ma, Chao, et al.
Publicado: (2022)